scale-up
A recipe that works beautifully for a single dinner often fails when you cook for five hundred — the pot heats differently, the spoon cannot reach the middle, timings shift. Scale-up is the disciplined transfer of a pharmaceutical process from small laboratory or pilot batches to full production scale, with the goal of keeping the product the same: same quality, same critical attributes, even though the equipment is far larger.
The difficulty is that processes do not scale linearly. When a blender or granulator gets bigger, surface area, mixing forces, heat transfer and drying rates do not all grow in the same proportion, so a setting that worked at 1 kg may over-shear, over-wet or under-dry at 300 kg. Engineers manage this by trying to keep meaningful quantities constant across scales — for example tip speed in a high-shear granulator or fluidisation velocity in a dryer — rather than just copying machine settings.
Scale-up is where many promising formulations stumble, which is why QbD aims to understand the process well enough that scale becomes just another studied variable. The honest reality is that some scale effects cannot be fully predicted and must be confirmed empirically at the target scale; this is precisely why process validation is performed on full-scale batches, and why a change of scale is treated as a change requiring re-evaluation.
Moving a high-shear granulation from a 10 L lab bowl to a 600 L production bowl, engineers keep the impeller tip speed similar rather than the rotation speed, because matching tip speed better preserves the shear the granules experience.
Sound scale-up matches the physics the product feels, not the machine's raw settings.
Continuous manufacturing partly sidesteps scale-up: instead of running a bigger machine, you run the same small equipment for longer to make more product, so scale becomes mostly a matter of run time.